We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$681B
AUM Growth
+$33.3B
Cap. Flow
+$8.08B
Cap. Flow %
1.19%
Top 10 Hldgs %
15.87%
Holding
7,749
New
618
Increased
3,173
Reduced
3,213
Closed
189

Sector Composition

Rank Sector Weight
1 Technology 18.57%
2 Healthcare 9.66%
3 Financials 8.97%
4 Communication Services 8.91%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORKA
5676
Oruka Therapeutics
ORKA
$7.11B
$149K ﹤0.01%
3,395
+3,072
+951% +$161K
DYFN
5677
DELISTED
Angel Oak Dynamic Financial Strategies Income Term Trust
DYFN
$149K ﹤0.01%
+7,883
New +$147K
FMBH icon
5678
First Mid Bancshares
FMBH
$1.38B
$148K ﹤0.01%
3,360
-12,848
-79% -$485K
NOCT icon
5679
Innovator Growth-100 Power Buffer ETF October
NOCT
$230M
$148K ﹤0.01%
4,000
ASLN
5680
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$148K ﹤0.01%
1,102
-930
-46% -$118K
DDMX
5681
DELISTED
DD3 Acquisition Corp. II Class A Common Stock
DDMX
$148K ﹤0.01%
+15,196
New +$154K
AIEQ icon
5682
Amplify AI Powered Equity ETF
AIEQ
$125M
$147K ﹤0.01%
3,845
+1,980
+106% +$77.2K
SUSC icon
5683
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
$147K ﹤0.01%
5,454
+2,580
+90% +$71K
USMF icon
5684
WisdomTree US Multifactor Fund
USMF
$305M
$147K ﹤0.01%
3,875
+277
+8% +$10.2K
ASC icon
5685
Ardmore Shipping
ASC
$681M
$146K ﹤0.01%
31,984
-11,902
-27% -$48.3K
GREK
5686
Global X MSCI Greece ETF
GREK
$331M
$146K ﹤0.01%
5,512
-3,349
-38% -$84.2K
SYBX
5687
DELISTED
Synlogic
SYBX
$146K ﹤0.01%
2,717
-3,621
-57% -$206K
NYMX
5688
DELISTED
Nymox Pharmaceutical Corp
NYMX
$146K ﹤0.01%
65,768
-35,979
-35% -$94.8K
TCFC
5689
DELISTED
The Community Financial Corporation Common Stock
TCFC
$146K ﹤0.01%
4,264
-3,675
-46% -$109K
BCLI
5690
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$145K ﹤0.01%
2,515
-11,685
-82% -$882K
HNW
5691
DELISTED
Pioneer Diversified High Income Fund
HNW
$144K ﹤0.01%
9,844
-6,118
-38% -$89.4K
PRAX icon
5692
Praxis Precision Medicines
PRAX
$10.8B
$144K ﹤0.01%
294
-661
-69% -$470K
STRT icon
5693
STRATTEC Security
STRT
$338M
$144K ﹤0.01%
3,069
+1,164
+61% +$59.8K
WINA icon
5694
Winmark
WINA
$1.26B
$144K ﹤0.01%
770
-2,211
-74% -$402K
YINN icon
5695
Direxion Daily FTSE China Bull 3X ETF
YINN
$651M
$144K ﹤0.01%
374
-566
-60% -$274K
PTRS
5696
DELISTED
Partners Bancorp Common Stock
PTRS
$144K ﹤0.01%
19,654
+6,188
+46% +$43K
CAPR icon
5697
Capricor Therapeutics
CAPR
$244M
$143K ﹤0.01%
30,450
-25,157
-45% -$145K
MTR
5698
Mesa Royalty Trust
MTR
$5.31M
$143K ﹤0.01%
30,000
+22,400
+295% +$107K
FPAC.U
5699
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
$143K ﹤0.01%
+14,169
New +$152K
LJAQU
5700
DELISTED
LightJump Acquisition Corporation Unit
LJAQU
$143K ﹤0.01%
+14,373
New +$148K

Similar funds

Morgan Stanley's Q1 2021 Portfolio in Review

As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 189 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
  • Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
  • Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
  • Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
  • Morgan Stanley opened 618 new positions and closed 189 in Q1 2021.
  • Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.

Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.